This is the CSO from Nanodiagnostics. Fair chance he knows what...

First 145 Last

Share
Profile

Follow
Quiltman

2,314 Posts.

2871

23/03/21

17:17

Post #: 51981430
Share

Originally posted by Quiltman: ↑

I'd be 100% confident NanoDiagnostics would be working 24/7 to get their NanoDX Covid19 solutioninto the market ASAP.
Sharad Joshi, President & CEO of NanoDiagnostics, published a video 3 to 4 months ago talking about the incredible pivot the company had made to move from TBI to Covid19, and received plaudits from many. His credibility, and that of the company, are on the line. It could be argued that they have more at stake than Sensera as we have plenty of other projects in the pipeline.

From the NanoDiagnostics website, a reminder of how Sensera nanosensors are crtical to their solution

The breakthrough science integrated into the NanoDx™ System is based upon the revolutionary work of Nanosys, Inc., a pioneer of nanoscale technology. The patented nanosensor design includes an array of ultrasensitive nanowires that detect and measure specific biomarkers and infections in the bloodstream or other fluid specimens. The unique size and electrical properties of the nanosensors allow detection of biomarkers and infections never before possible in a simple, portable, point-of-care system.

I remain confident NanoDX will gain FDA EUA clearance. We just need to remain patient.

“Most people are too fretful, they worry too much. Success means being very patient, but aggressive when it’s time.” Charlie Munger

GLTAH. IMO

Expand

This is the CSO from Nanodiagnostics. Fair chance he knows what he is doing !

Meet our Chief Scientific Officer, Dr. Sergey Dryga!

Dr. Dryga joined NanoDx in 2014 and has extensive experience in building cross-functional R&D teams and leading development of In Vitro Diagnostics, reagents and vaccines. Dr. Dryga is an experienced product-development leader with expertise in nano-biotechnology, molecular biology, protein engineering, system integration, and electrical and software engineering. Dr. Dryga has a Masters Degree in BioOrganic Chemistry (NSU, Russia), PhD in Molecular Biology (IMB, Russia) and MBA from Kenan-Flagler Business School (UNC). He completed post-doctoral training at Washington University in St. Louis in the lab of Prof. S. Schlesinger, where he studied replication of alphaviruses.

SE1 Price at posting: 6.7¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

CXU

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

ASX Market Open: Australian bourse to fall as subdued Wall Street awaits rate cut decision | September 18, 2024

PAR

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

There are more pages in this discussion • 9 more messages in this thread...

First 145 Last

Add SE1 (ASX) to my watchlist

This is the CSO from Nanodiagnostics. Fair chance he knows what...

Top Stories

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

ASX Market Open: Australian bourse to fall as subdued Wall Street awaits rate cut decision | September 18, 2024

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

Featured News